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Abstract The loss of photoreceptors is the deﬁning
characteristic of many retinal degenerative diseases, but the
mechanisms that regulate photoreceptor cell death are not
fully understood. Here we have used the 661W cone pho-
toreceptor cell line to ask whether exposure to the terminal
complement complex C5b-9 induces cell death and/or
modulates the sensitivity of these cells to other cellular
stressors. 661W cone photoreceptors were exposed to
complete normal human serum following antibody block-
ade of CD59. Apoptosis induction was assessed morpho-
logically, by ﬂow cytometry, and on western blotting by
probing for cleaved PARP and activated caspase-3. Nec-
roptosis was assessed by ﬂow cytometry and Sirtuin 2
inhibition using 2-cyano-3-[5-(2,5-dichlorophenyl)-2-
furyl]-N-5-quinolinylacrylamide (AGK2). The sensitivity
of 661W cells to ionomycin, staurosporine, peroxide and
chelerythrine was also investigated, with or without prior
formation of C5b-9. 661W cells underwent apoptotic cell
death following exposure to C5b-9, as judged by poly(-
ADP-ribose) polymerase 1 cleavage and activation of
caspase-3. We also observed apoptotic cell death in
response to staurosporine, but 661W cells were resistant to
both ionomycin and peroxide. Interestingly, C5b-9
signiﬁcantly increased 661W sensitivity to staurosporine-
induced apoptosis and necroptosis. These studies show that
low levels of C5b-9 on 661W cells can induce apoptosis,
and that C5b-9 speciﬁcally sensitizes 661W cells to certain
apoptotic and necroptotic pathways. Our observations
provide new insight into the potential role of the comple-
ment system in photoreceptor loss, with implications for
the molecular aetiology of retinal disease.
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Introduction
The complement system acts as the frontline defence against
invading pathogens, and it facilitates the removal of modi-
ﬁed and dead host cells upon activation by three distinct
modalities, which are the classical, the alternative and the
lectin pathways [1, 2]. However, individual complement
proteins are increasingly linked with distinct activities that
lie beyond their roles in host defence. For example, the
classical pathway, through the activity of C1q, has been
shown to play a key developmental role in synaptic pruning
in the central nervous system (CNS) [3], and complement
proteins are widely reported to be up-regulated in a variety
of CNS diseases [4]. Although each pathway has its own
mechanism of activation that enables it to distinguish
between foreign and host cells, all converge on the forma-
tion of the terminal C5b-9 complex (also known as mem-
brane attack complex, or MAC), which creates pores on cell
membranes and in certain cell types may cause lysis and
apoptosis. Formation of C5b-9 begins with the binding of
C5b6 to the plasma membrane of the target cell, with sub-
sequent recruitment of complement proteins C7 and C8, and
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C9 proteins to form the lytic pore.
In general, cells protect themselves from excessive
complement activation through ﬂuid-phase regulators such
as complement factor H (CFH) and cell membrane mole-
cules such as CD59 and decay accelerating factor (DAF),
which prevent the formation of C5b-9 complexes [5]. The
requirement for protection against complement activation
clearly exists in the retina since rod and cone photorecep-
tors in human eyes, and astroglial cells in mouse eyes have
been shown to express DAF [6, 7], and we also reported
that CD59a and CFH are up-regulated in the mouse neu-
roretina in normal ageing, again supporting the idea that
complement regulation is required for maintenance of a
healthy retina [8].
Understanding how photoreceptors die in retinal degen-
eration is important for the future development of thera-
peutics, but the mechanisms of cell death have yet to be fully
elucidated. There is compelling evidence that apoptosis
plays an important role [9–11], but necrotic cell death also
occurs in mouse models of photoreceptor loss and other
forms of neurodegeneration [10], and multiple proteases
have been reported to be involved in programmed cell death
in 661W cone photoreceptors [12]. Given the central
importance of cone cell death in age-related macular
degeneration (AMD), and the evidence of increased com-
plement activation in AMD [13], we undertook this study to
ﬁnd out whether C5b-9 could induce 661W death or sensi-
tize 661W cells to conventional apoptotic agonists. We
observed that C5b-9 assembly on 661W cells led to apop-
totic cell death, and that sub-lethal levels of C5b-9 increased
the sensitivity of these cells to apoptosis and necroptosis
induced by staurosporine, but not peroxide or ionomycin.
Apoptosis and necroptosis differ in that the former refers to
a series of morphological and biochemical changes, typi-
cally involving caspase activation, nuclear condensation and
membrane blebbing, while the latter describes a form of
unprogrammed cell death that does not involve caspases,
and that is frequently associated with activation of the tissue
necrosis factor-a receptor (TNFR).
Materials and methods
Cell culture
The photoreceptor cell line (661W) was a generous gift of
the Agarwal laboratory. The line was originally provided as
RGC-5 but this has since been shown to be identical to
661W [14], and this is re-conﬁrmed here. Cells were rou-
tinely maintained in Dulbecco’s modiﬁed Eagle’s medium
with glutamine (Invitrogen), supplemented with 10 % fetal
bovine serum (Gibco) and 100 U/ml penicillin/
streptomycin (Gibco). We undertook a PCR-based valida-
tion of the cells to exclude any possibility that they might
be rat ganglion cells. The primers we used were as fol-
lows—note that all primer sequences are written 50–30, with
the forward primer sequence ﬁrst: Mouse b-globin,
CCTGTGGGGAAAGGTGAAC and ATACCAGATACC
TGCA GGCTTAT; Rat b-actin, GGCTTTAGGAGCTTG
ACAATACTG and GCATTGGTCACCTTT AGATGGA;
mouse Nrl, TGTCTGTGCGCGAGTTGAAC and AAGAG
GTGTCGTCTGTGTGG; mouse rhodopsin, CACTCGTT
GGCT GGTCCAGGTAC and AGCCGCCTCCTTGACTG
TGAAGA; mouse GNAT2, GCATCAGTGCTGAGGA
CAAA and CTAGGCACTCTTCGGGTGAG; mouse SWL
opsin, TGTACATGGTCAACAATCGGA and ACACCAT
CTCCAGA ATGCAAG; mouse MWL opsin, CTCTGCT
ACCTCCAAGTGTGG and AAGTATAGGGTCCCCAGC
AGA.
C5b-9 formation
Seventy to eighty percentage conﬂuent 661W cells were
starved in serum-free medium for 24 h, then treated with a
rabbit polyclonal anti-human CD59 antiserum (a generous
gift from Prof BP Morgan, Cardiff University, Cardiff, UK)
for 1 h at 37 C. Cells were washed with PBS and incu-
bated with normal human serum (NHS) (Jackson Immuno
Research) for 1 h. Heat-inactivated (HI) NHS (30 min at
56 C) was used as the complement-deﬁcient control. In
some experiments NHS was replaced with C7-deﬁcient
human serum (CompTech Texas, USA), in the presence or
absence of complement C7 puriﬁed from human serum
(Sigma). Afterwards, the cells were washed with PBS and
supplied with complete medium.
MTT viability assay
661W cells were seeded at 10
3 cells per well in 96-well
plates and serum-starved for 24 h. After the induction of
C5b-9 formation (see earlier), cells were incubated with
100 ll/ml MTT (5 mg/ml thiazolyl blue) in sterile phos-
phate buffered saline (PBS) at 37 C for 3 h until formazan
crystals appeared. After removing the supernatant, 100 ll
of DMSO (Sigma) was added to solubilize the formazan
product. Absorbance was measured at 570 nm using a
spectrophotometer plate reader (Fluostar Optima).
Immunoﬂuorescence
661W cells grown on coverslips were serum-starved as
described above and induced to form C5b-9. Cells were
ﬁxed with 4 % paraformaldehyde in PBS at 4 C for
20 min, permeabilized with 0.2 % Triton X-100 for 30 min
and blocked with 1 % bovine serum albumin (BSA)
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123(Sigma-Aldrich) at room temperature for 1 h before incu-
bation with the anti-C5b-9 antibody (Dako, 1:50) at 4 C
overnight. The cells were then washed three times using
PBS, and incubated with anti-mouse IgG secondary anti-
body conjugated to Alexa Fluor 488 for 1 h at room tem-
perature in the dark. In some experiments rhodamine-
phalloidin (Invitrogen, 1:200) was also applied to observe
the F-actin cytoskeleton. Finally, cells were washed three
times with PBS and mounted with Vectashield mounting
media in the presence of DAPI (Vector Laboratories,
Burlingame, CA, USA). Images were acquired using a
Leica TSC-SP2 laser scanning confocal microscope (Leica
Microsystems GmbH, Wetzlar, Germany).
Western blotting
70–80 % conﬂuent 661W cells were serum-starved in
6-well plates for 24 h, and induced for C5b-9 formation.
Afterwards the cells were washed gently with PBS and
incubated with 100nM staurosporine (Sigma), 1 lM iono-
mycin (Sigma), 4 lM chelerythrine (Sigma) or 10 lM
H2O2 (Sigma) in complete medium. In some experiments
the concentrations of agonists were varied as detailed in the
12341234
mouse ß-globin rat ß-actin
a
b
1234 1234 123412341234
Nrl Rhodopsin GNAT2 SWL opsin MWL opsin
Fig. 1 Validation of the 661W cell line. a We used mouse and rat
genomic DNA as templates to conﬁrm the species of the cell line,
with mouse ß-globin and rat ß-actin probes respectively. Lane 1
661W cell genomic DNA; Lane 2 rat genomic DNA; Lane 3 mouse
genomic DNA; Lane 4 water (negative control). b We then used a set
of mouse-speciﬁc retinal primers as indicated in the ﬁgure to assess
expression of rod and cone markers in the cell line. Lane 1 661W cell
cDNA; Lane 2 mouse neuroretina cDNA (positive control); Lane 3
mouse liver cDNA (negative control); Lane 4 water (negative control)
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Fig. 2 Formation of C5b-9 on
661W cells. a MTT viability
assay measuring the extent of
661W cell death following
treatment with blocking
antibodies to CD59 and
increasing concentrations (5, 15,
25, 30 %) of NHS for 1 h at
37 C. For the negative control,
cells were treated with anti-
CD59 and 30 % HI-NHS, and
for the positive control with 1 %
Triton X-100. Data are plotted
as mean ± S.D. (n = 3).
b 661W cells were
immunostained for C5b-9 and
counterstained with DAPI to
visualise nuclei. Cells were
treated with 5 % NHS alone,
anti-CD59? 5 % NHS, 10 %
NHS alone, or anti-CD59?
10 % NHS. C5b-9 was barely
visible at the lower serum
concentration or in cells that
weren’t treated with the CD59
blocking antibody, but appeared
in punctate form in cells
exposed to 10 % NHS (zoomed
image). Scale bar = 10 lm. All
experiments were repeated at
least three times, and
representative images are shown
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123ﬁgure legends. Cells were then lysed using RIPA buffer
supplemented with protease inhibitors (Roche, West Sus-
sex, UK). Protein concentrations were measured using the
Bio-Rad Assay and 30 lg were separated by 10 % SDS-
PAGE and transferred to a PVDF membrane. Antibodies
against Poly (ADP-ribose) polymerase (PARP), cleaved
caspase-3, GAPDH and a-tubulin were purchased from
Cell Signaling Technology, Beverly, MA. Protein bands
were visualized by chemiluminescence using ECL
substrate (Thermo Scientiﬁc Pierce Protein Research
Products).
Flow Cytometry
For quantitation of apoptosis, cells were serum-starved in
6-well plates for 24 h and induced for C5b-9 formation.
Cells were then washed gently with PBS and incubated
with a range of concentrations of staurosporine or
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Fig. 3 C5b-9 induces signature features of apoptosis in 661W cells in
a dose- and time-dependent manner. a 661W cells were serum-starved
for 24 h, then treated with anti-CD59 for 1 h followed by 5 % NHS
for 1 h. Cells were lysed after 0, 4, 8 and 20 h and subjected to
immunoblot analysis for PARP and cleaved caspase 3. Cells were
treated with 5 % HI-NHS as a negative control and a-tubulin was
included as a loading control. The blot shows that cleavage of PARP
and activation of caspase-3 after 20 h occurred only in cells treated
with NHS. b 661W cells were prepared as in (a), and treated with
different concentrations of NHS for 20 h before immunoblotting.
PARP cleavage and caspase-3 activation were faintly evident in 1 %
NHS, but strikingly so in 2 and 5 % NHS. c 661W cells were prepared
as in (a) with exposure to NHS for 20 h, then ﬁxed, immunostained
for C5b-9 and F-actin with nuclear counterstaining, and examined by
confocal microscopy to investigate morphological changes. The
images show that in 0 and 1 % NHS, 661W cells maintained a normal
healthy morphology with abundant F-actin stress ﬁbres, whereas in
5 % NHS surviving cells typically were smaller with fewer stress
ﬁbres and F-actin clumping. Scale bar 10 lm. All experiments were
repeated at least three times, and representative blots/images are
shown
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123chelerythrine for 4 and 8 h. In some experiments cells were
also treated with 10 lM AGK2 (Sigma). The apoptotic
661W cells were measured with an annexin V/propidium
iodide (PI) apoptosis detection kit (BD Biosciences,
Montreal, Quebec, Canada) according to the manufac-
turer’s instructions. Brieﬂy, cells were trypsinized and
pelleted by centrifugation, washed once with ice-cold PBS,
resuspended in 19 Binding Buffer at a concentration of 1
9 10
6 cells/ml, from which 100 ll of cell suspension (1 9
10
5 cells) was transferred to a 5 ml Falcon tube. Cells were
ﬁrst incubated with 5 ll FITC-Annexin V and 5 ll PI for
15 min at RT (25 C) in the dark, then 400 llo f1 9
Binding Buffer was added to each tube. The cell suspen-
sion was then analysed by Cyan FACS analyser, FlowJo
was used for data analysis. The results are presented as the
percentage of cells that were early apoptotic (Annexin-V
?
PI
-) or necroptotic (Annexin-V
? PI
?).
Statistical analysis
The data are represented as mean and standard error of at
least three independent experiments. Statistical compari-
sons were made using a two-tailed Student’s t test. Sig-
niﬁcant differences were deﬁned as P\0.05.
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Fig. 4 C7 is required for C5b-9 formation. Serum-deprived and anti-
CD59 treated 661W cells were treated with either C7-depleted NHS
(10 or 20 % for 60 min) or C7-depleted serum supplemented with
puriﬁed exogenous C7 (100 lg/ml) (10 or 20 % for 60 min).
Immunoﬂuorescence staining and confocal imaging of C5b-9 and
F-actin shows that in cells treated with C7 deﬁcient serum, cellular
morphology was normal with abundant F-actin stress ﬁbres, and no
evidence of C5b-9 staining. Restoration of C7 led to the appearance
of punctate C5b-9 staining, and characteristic disruption of the F-actin
cytoskeleton. DAPI was used to stain the nuclei. Scale bar 10 lm. All
experiments were repeated at least three times, and representative
images are shown
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123Results
Cell line validation
Because of recent issues surrounding the identity of certain
ocular cell lines [14], we used PCR to conﬁrm that the cell
line used in this study was indeed 661W. First we estab-
lished that the line was of mouse origin, by using primers
speciﬁc for mouse ß-globin and rat ß-actin against a
genomic DNA template. Bands of the expected size were
produced from our 661W cells and control mouse DNA,
whereas the rat probes failed to generate a product from our
cells (Fig. 1a). We then used a number of photoreceptor-
speciﬁc probes, with mouse retina cDNA as a positive
control in each case, to test for expression of rod and/or
cone markers. Our 661W cells failed to yield products for
Nrl and rhodopsin, but we observed products for GNAT2
and SWL opsin (Fig. 1b). We did not observe a PCR
product using the MWL opsin probes. Taken together,
these results show that our cell line is of mouse origin and
that it expresses cone photoreceptor markers, consistent
with it being the 661W line.
C5b-9 formation on 661W cells
To determine the tolerance of 661W cells to the terminal
complement complex, cells were incubated ﬁrst with rabbit
polyclonal antiserum to CD59 and then switched to med-
ium containing a range of concentrations of normal human
serum (NHS), with 30 % heat-inactivated (HI)-NHS
employed as control. The MTT assay shows that NHS was
required to induce cell death (Fig. 2a), and that cell via-
bility decreased with increasing concentrations of NHS,
whereas treatment with the combination of anti-CD59 and
HI-NHS had no effect on the cell viability. There was
approximately 5 % cell death in the presence of 5 % NHS,
and almost 50 % cell death in the presence of 30 % NHS.
To conﬁrm the presence of C5b-9 on the 661W cells under
these experimental conditions we performed immunoﬂuo-
rescence analysis in conjunction with confocal microscopy,
and observed characteristic punctate staining [15] only on
661W cells treated with the anti-CD59 blocking antibody
and 5 or 10 % NHS, and not on cells treated with NHS
alone (Fig. 2b).
C5b-9 formation promotes apoptosis of 661W cells
To determine if C5b-9 formation promoted cell apoptosis,
we used western blotting of whole cell lysates to examine
poly (ADP-ribose) polymerase (PARP), a 116 kDa protein
that is cleaved by activated caspase-3, and cleaved/acti-
vated caspase-3 as positive apoptotic markers. The blots
showed that PARP and caspase-3 cleavage were evident
20 h after 1 h treatment of anti-CD59 and 5 % NHS
respectively (Fig. 3a). In contrast, there was no PARP
cleavage or caspase-3 activation when cells were treated
with anti-CD59 and 5 % HI-NHS. These results show that
C5b-9 formation is sufﬁcient to stimulate 661W cell
apoptosis, and are consistent with observations in animal
models of retinal degeneration [16]. A dose–response
experiment was also performed, and this showed that
cleavage of PARP and activation of caspase-3 were just
detectable in cells exposed to 0.5 % NHS and increased
markedly up to 5 % NHS (Fig. 3b). We also investigated
morphological changes in 661W cells under these condi-
tions, and observed that 5 % NHS induced the formation of
C5b-9, cell shrinkage and disassembly of F-actin stress
ﬁbres that was not observed in cells treated with 0 or 1 %
NHS (Fig. 3c).
C7 is required for C5b-9 formation and 661W apoptosis
To conﬁrm that 661W apoptosis was indeed induced by
activation of complement, and not another heat-sensitive
constituent of serum, we investigated C5b-9 assembly on
661W cells using C7-depleted normal human serum (C7-
NHS) and C7-NHS supplemented with puriﬁed C7
(C7?NHS). Immunoﬂuorescence analysis revealed no
C5b-9 staining or morphological changes, as judged by
F-actin staining, when cells were treated with 10 or 20 %
C7-NHS (Fig. 4). In contrast, cells treated with either 10 or
20 % C7?NHS showed clear patchy C5b-9 staining and
changes in morphology including shrinkage and clumping
of F-actin bundles consistent with the early stages of
apoptosis [17]. These experiments conﬁrm that the effects
of NHS that we observe are due to the presence of C5b-9
on 661W cells and not a non-speciﬁc labile component of
serum.
bFig. 5 C5b-9 sensitizes 661W cells to staurosporine-mediated apop-
tosis. Cell apoptosis was detected by immunoblotting for PARP
cleavage and activated caspase 3. a Serum-deprived and anti-CD59
treated 661W cells were incubated with increasing concentrations of
NHS (0, 0.1, 0.5, 1, 2, 5 %) for 1 h, then with complete medium alone
or with 100nM staurosporine (SS), 1 lM ionomycin (INM) or 10 lM
H2O2 for 8 h. b 661W apoptosis was compared between cells treated
with 100 nM staurosporine or medium alone for 0, 4, 8 and 20 h,
which revealed PARP cleavage and caspase-3 activation only at 20 h.
The kinetics of staurosporine-induced apoptosis were then investi-
gated following treatment of 661W cells with either 5 % NHS or 5 %
HI-NHS for 1 h, which revealed PARP cleavage and caspase-3
activation at 8 h only in the presence of 5 % NHS. c 661W cells were
treated with a range of concentrations of chelerythrine for 4, 8 and
12 h. The immunoblots show rapid onset of PARP cleavage and
caspase-3 activation with 10 and 20 lM agonist. d The sensitivity of
661W cells to chelerythrine was examined with and without prior
exposure to 5 % NHS or 5 % HI-NHS. The immunoblots show that at
4 and 8 h, there was no difference between 5 % NHS and 5 % HI-
NHS, though in both conditions PARP cleavage and caspase-3
activation were enhanced compared to chelerythrine alone (c)
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123C5b-9 modulates 661W cell sensitivity to apoptosis
Next we examined whether assembly of C5b-9 on the
surface of 661W cells alters their sensitivity to agents
known to induce apoptosis. As we had previously shown
that there was no PARP cleavage or caspase-3 activation at
8 h post induction of C5b-9 formation in the presence of
5 % NHS (Fig. 3a), we therefore incubated 661W cells
with various concentrations of NHS (0–5 %) for 8 h in the
presence of staurosporine, ionomycin and H2O2. Figure 5a
shows that of these three agonists only staurosporine
induced PARP cleavage and caspase-3 activation, and that
this was markedly enhanced in cells treated with higher
concentrations of NHS (1, 2, 5 %).
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Fig. 6 Chelerythrine and staurosporine induce apoptosis and necrop-
tosis in 661W cells. Cell death was examined by Annexin V/PI
staining and ﬂow cytometry. a Quantitation of apoptotic 661W cells
following treatment with a range of concentrations of staurosporine
(0–100 nM) for 4 h and 8 h in the presence of 5 % NHS or 5 % HI-
NHS. b Example of the primary data for the 8 h, 100 nM
staurosporine experiment. Apoptotic cells are Annexin V
? and locate
to the top-left quadrant of the scatter plot whereas necroptotic cells
are Annexin V and PI double positive and locate to the upper right
quadrant. c Quantitation of necroptotic 661W cells from the same
experiment as (a) and (b). d Necroptotic 661W cells were quantiﬁed
as in (c) following treatment with 100 nM staurosporine for
8h± 10 lM AGK2. Necroptosis was signiﬁcantly inhibited by
AGK2. e Serum-starved and anti-CD59 treated 661W cells were
incubated with 5 % NHS or 5 % HI-NHS for 1 h and then incubated
with 0–20 lM chelerythrine for 4 or 8 h. Cells were then stained and
subjected to ﬂow cytometry as described above. The bar charts show
the percentages of apoptotic cells. f Quantitation of necroptotic 661W
cells from the same experiment as (e). g Representative scatter plots
showing the results for cells treated with 20 lM chelerythrine for 8 h.
(*P\0.05, **P\0.01, n = 3)
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123We then asked whether PARP cleavage and caspase-3
activation were dependent on the combination of C5b-9
and staurosporine, or due solely to the staurosporine. Fig-
ure 5b shows that within the 8 h time frame staurosporine
alone was insufﬁcient to cause PARP cleavage and cas-
pase-3 activation, but did cause modest PARP cleavage by
20 h. However, concomitant incubation with 5 % NHS
greatly increased PARP cleavage and caspase-3 activation
compared to 5 % HI-NHS. Several groups have reported
that staurosporine can be used to induce 661W apoptosis
[18, 19], with similar slow kinetics to those we observe
here. Staurosporine is a broad-spectrum protein kinase
inhibitor [20], but the mechanism whereby it induces
apoptosis is not understood. We therefore compared the
effects of staurosporine on 661W cells with chelerythrine, a
more speciﬁc inhibitor of protein kinase C (PKC). We
observed that chelerythrine alone induced PARP cleavage
and caspase-3 activation in a dose- and time-dependent
manner (Fig. 5c), but that in contrast to staurosporine,
PARP cleavage and caspase-3 activation were not poten-
tiated by C5b-9 (Fig. 5d).
Taken together these results reveal 661W cells to be
remarkably resistant to levels of calcium cytotoxicity and
oxidative stress that would readily kill many other cell
types, but to be more susceptible to protein kinase inhibi-
tors, with prior formation of C5b-9 sensitizing 661W cells
to staurosporine but not to chelerythrine.
661W cells die by both apoptosis and necroptosis
To more accurately quantify 661W death and to corrob-
orate the results of the western blots in Fig. 5, we used
ﬂow cytometry with annexin V (AnxV) and propidium
iodide (PI) staining to identify cells undergoing apoptosis
and necrosis respectively. Figures 6a, b conﬁrmed that
5 % NHS, but not 5 % HI-NHS, signiﬁcantly increased
the percentage of apoptotic cells (AnxV
? PI
-)
(*P\0.05, **P\0.01) in the presence of staurosporine
(0, 20, 40 and 100 nM) at both 4 and 8 h. Notably, the
fold differences in the number of apoptotic cells when
comparing NHS and HI-NHS were approximately 4–5
(4 h) and 6–8 (8 h) in the presence of staurosporine, but
only 1–2 (4 h) and 2–3 (8 h) in the absence of stauro-
sporine. Intriguingly, we observed many fewer cells
positive for PI alone, but a signiﬁcant pool of cells
(*8 %) that were AnxV
? PI
?, a hallmark characteristic
of necroptosis, or programmed necrosis (Fig. 6c). The
necroptotic and apoptotic pools were evident only in the
presence of C5b-9, and generation of the necroptotic pool
was signiﬁcantly inhibited by AGK2 (*P\0.05, Fig. 5d),
a pharmacological inhibitor of SIRT2 deacetylase activity
[21] that has recently been shown to be required for
programmed necrosis [22]. In contrast to the results
obtained with staurosporine, the sensitivity of 661W cells
to the PKC inhibitor chelerythrine was much less affected
by the presence of C5b-9. Thus, chelerythrine rapidly
induced both apoptosis and necroptosis, with the number
of apoptotic (AnxV
? PI
-) cells exceeding necroptotic
(AnxV
? PI
?) cells at 4 h, with the converse at 8 h
(Figs. 6e–g). A small but signiﬁcant increase in the
number of apoptotic cells was associated with C5b-9 after
8 h treatment with chelerythrine (**P\0.01, Fig. 6e).
Discussion
Photoreceptor cell death is responsible for the majority of
registered blindness and vision loss, so there is a need to
improve our understanding of the cellular mechanisms that
drive this process in order to develop new and more
effective therapies. Recently it has become clear that
although apoptosis may account for a signiﬁcant fraction of
photoreceptor loss, other pathways, in particular necrosis
and necroptosis, appear to play a signiﬁcant role [23].
Photoreceptor loss in AMD is generally considered to
occur secondary to retinal pigment epithelial (RPE) cell
death or dysfunction caused by inadequate control of
complement activation [13]. There is therefore a clinical
parallelism in AMD pathology in which RPE cells and
cone photoreceptors both degenerate, though not neces-
sarily simultaneously. Whilst little is known about the
effects of complement activation on photoreceptors, studies
on C5b-9 formation on RPE cells have reported both cell
death at high levels, and modulation of RPE gene expres-
sion at lower, sublytic levels [24, 25]. Whilst the RPE/
Bruch’s membrane may be the primary site of comple-
ment-mediated cell damage, the expression of complement
regulatory proteins in the neural retina [6] suggests that in
disease, photoreceptors may themselves become vulnerable
to direct assault from C3 and its breakdown products or
C5b-9.
In this study we describe a protocol for the assembly of
sub-lytic levels of C5b-9 on 661W cells. C5b-9, or mem-
brane attack complex, forms pores in cell membranes but
most nucleated cells have mechanisms to escape lysis
induced by C5b-9, typically eliminating the cell surface
complex either by vesicular shedding or endocytosis and
lysosomal degradation [15, 26]. However, we found that
661W cells underwent limited apoptosis as a consequence
of C5b-9 exposure in the absence of any other insult, albeit
relatively slowly. We also observed that C5b-9 rendered
661W cells particularly sensitive to death by staurosporine,
a broad-speciﬁcity protein kinase inhibitor that has been
shown to induce apoptosis in many cell types, including
661W cells [18, 19]. Here, we also observed apoptosis of
661W cells, as judged by PARP cleavage, activation of
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exposed to staurosporine.
Although we found 661W cells to be highly resistant to
oxidative stress, ﬂow cytometric analysis revealed that both
staurosporine and chelerythrine induced not only AnxV
?
cells typically associated with apoptosis, but also AnxV
?
PI
? cells. Positivity for PI alone is a characteristic of
necrosis, but the double positivity observed here is con-
sistent with programmed necrosis, or necroptosis, sug-
gesting that staurosporine and chelerythrine can
simultaneously induce both apoptosis and necroptosis in
661W cells. Interestingly, 661W cells have also been
reported to undergo cell death by necrosis in response to
light exposure [27, 28]. Necroptosis is a form of cell death
particularly associated with neurodegenerative disease that
may be initiated by death receptors such as the tumour
necrosis factor receptor 1 in association with the RIP1 and
RIP3 kinases [29, 30]. The NAD-dependent deacetylase
SIRT2 has also recently been shown to be required for
necroptosis [22], and here we showed that the SIRT2
inhibitor AGK2 attenuated the generation of AnxV
? PI
?
661W cells in response to staurosporine. Our observation
that staurosporine can induce both apoptosis and necrop-
tosis in complement-sensitized 661W cells is consistent
with reports that both forms of cell death have been
observed in response to staurosporine in rat astrocytes [31],
and also in our own prior in vivo observations of AnxV
?
PI
? RGCs following intravitreal injection of either
staurosporine or amyloid ß in mouse eyes [32].
Conclusions
In conclusion, the results of our study add weight to the idea
that complement dysregulation may play a role in the
molecular pathogenesis of retinal diseases characterised by
the death of cone photoreceptors. In AMD, where comple-
ment is already clearly implicated in a causative role, loss of
macular cones is a major cause of vision loss and our results
here suggest that complement activation may either directly
cause cone cell death, or sensitize cones to other insults. Our
results also suggest that apoptosis may not be solely respon-
sible for cone cell death in retinal degeneration. Although we
identiﬁed apoptosis and necroptosis using staurosporine,
which is not a physiological agonist, necroptosis is strongly
linked to tumour necrosis factor-a (TNF-a)s i g n a l l i n g[ 33,
34], and aberrant TNF-a signalling has been extensively
linked to retinal degeneration [27, 35, 36]a n dA M D[ 37]. In
future work we will use rodent models of cone loss to inves-
tigate whether there is a functional link between complement
dysregulation, TNF-a signalling and necroptosis.
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